Clinical trial
Phase IV Study of the Choice of Optimal Strategy for Bifurcation Lesions With Normal Side Branch
NCT00694005 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase IV Study of the Choice of Optimal Strategy for Bifurcation Lesions With Normal Side Branch
- Lead sponsor
- Seung-Jung Park
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- January 31, 2015
- Enrollment
- 504 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.